[111In]DOTA-sst2-ANT

N/A

Report date: 2025/11/24 17:58:32
NME

Base Information

Drug Name[111In]DOTA-sst2-ANT
Drug Alias NameDOTA-BASS111In-DOTA-BASSDOTA-BASS-[111In]Indium-111-DOTA-BASS
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Indium > 111In +[5] 
Mechanisms of ActionSomatostatin receptor antagonists
TargetsSomatostatin receptor
Therapy Area/IndicationsDiagnostic agents
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSalk Institute for Biological StudiesUniversitaet BernUniversitaetsspitals Basel
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversitaet BernSalk Institute for Biological StudiesUniversitaetsspitals Basel
Active IndicationsN/A
Inactive IndicationsDiagnostic agents

Other Information

ATC CodeN/A
Related LinksN/A